EUVIMEDOpdag EUVIMED
Fallbericht

Medication‐related osteonecrosis of the jaw in an older patient with multiple myeloma

Larissa Couto de Freitas, Vanessa Silvestre de Aquino Silva, Marta Miyazawa iD, Carine Ervolino de Oliveira iD, Felipe Fornias Sperandio iD, João Adolfo Costa Hanemann iD

Gerodontology · 2025

DOI: 10.1111/ger.12758 ↗

At a glance

Fallbericht in Gerodontology, 2025. Written by Larissa Couto de Freitas and 5 co-authors. Institution: School of Dentistry, Federal University of Alfenas, Alfenas, Minas Gerais, Brazil. Major MEDLINE topics: Multiple Myeloma, Bisphosphonate-Associated Osteonecrosis of the Jaw, Bone Density Conservation Agents, Diphosphonates. Cited 1 times so far (Crossref); 39 references. Funded by: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

This article reports a case of medication‐related osteonecrosis of the jaw (MRONJ) associated with multiple myeloma (MM).

Background

Bisphosphonates (BPs) are constantly used as part of the treatment for MM. The main adverse effects of bisphosphonates are renal insufficiency and medication‐related osteonecrosis of the jaw (MRONJ). Materials and Methods A 67‐year‐old female with a previous diagnosis of MM and undergoing current receiving intravenous injections of pamidronate underwent a tooth extraction and subsequently developed MRONJ.

Results

MRONJ was managed with clindamycin, surgical removal of bony sequestrum and curettage. At 3 years of follow‐up, the patient was asymptomatic with no clinical changes and panoramic radiography without evidence of recurrence.

Conclusion

Management of patients under antiresorptive drugs who require invasive dental procedures is challenging. Therefore, interprofessional collaboration, especially between the general practitioner and oncologist and/or haematologist, is essential to reach the best clinical approach and reduce the risk of MRONJ.

Subjects

MeSH terms (MEDLINE)

Multiple MyelomaBisphosphonate-Associated Osteonecrosis of the JawBone Density Conservation AgentsDiphosphonatesHumansFemaleAgedPamidronateRadiography, PanoramicTooth Extraction

Author keywords

bisphosphonatesmedication‐related osteonecrosis of the jawmultiple myeloma

Substances

PamidronateBone Density Conservation AgentsDiphosphonates

Authors and institutions

  • School of Dentistry, Federal University of Alfenas, Alfenas, Minas Gerais, Brazil.
  • Departament of Pathology and Parasitology, Biomedical Science Institute, Federal University of Alfenas, Alfenas, Minas Gerais, Brazil.
  • College of Dentistry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

ORCID profiles: Marta Miyazawa, Carine Ervolino de Oliveira, Felipe Fornias Sperandio, João Adolfo Costa Hanemann

Funding

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Cite

APA

de Freitas, L. C., de Aquino Silva, V. S., Miyazawa, M., de Oliveira, C. E., Sperandio, F. F., & Hanemann, J. A. C. (2025). Medication‐related osteonecrosis of the jaw in an older patient with multiple myeloma. Gerodontology. https://doi.org/10.1111/ger.12758

Vancouver

de Freitas LC, de Aquino Silva VS, Miyazawa M, de Oliveira CE, Sperandio FF, Hanemann JAC. Medication‐related osteonecrosis of the jaw in an older patient with multiple myeloma. Gerodontology. 2025. doi:10.1111/ger.12758

BibTeX
@article{deFreitas2025,
  author = {de Freitas, Larissa Couto and de Aquino Silva, Vanessa Silvestre and Miyazawa, Marta and de Oliveira, Carine Ervolino and Sperandio, Felipe Fornias and Hanemann, João Adolfo Costa},
  title = {Medication‐related osteonecrosis of the jaw in an older patient with multiple myeloma},
  journal = {Gerodontology},
  year = {2025},
  doi = {10.1111/ger.12758}
}
Start for free →